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Abstract
Background: The clinical presentation in progressive supranuclear palsy (PSP), an atypical parkinsonian disorder,
includes varying degrees of frontal dysexecutive symptoms. Using diffusion tensor imaging (DTI) and tractography
(DTT), we investigated whether diffusion changes and atrophy of the inferior fronto-occipital fasciculus (IFO) occurs
in PSP and if these changes correlate with disease stage and clinical phenotype. The corticospinal tract (CST),
which is often involved in PSP, was investigated for comparison.
Methods: DTI of the whole brain was performed with a 3 T MR scanner using a single shot-EPI sequence with
diffusion encoding in 48 directions. Scans were obtained in patients with PSP (n = 13) and healthy age-matched
controls (n = 12). DTT of the IFO and CST was performed with the PRIDE fibre tracking tool (Philips Medical
System). Fractional anisotropy (FA) and apparent diffusion coefficient (ADC) were calculated and correlated with
disease stage and clinical phenotype.
Results: In patients with PSP, significantly decreased FA and increased ADC was found in the frontal part of IFO
compared with the medial and occipital parts of IFO, as well as compared to controls. Four of the thirteen patients
with PSP showed a marked decrease in the number of tracked voxels in the frontal part of IFO. These findings
were most pronounced in patients with severe frontal cognitive symptoms, such as dysexecutive problems, apathy
and personality change. There was a strong correlation (r
2 = -0.84; p < 0,001) between disease stage and FA and
ADC values in the CST.
Conclusions: DTT for identification of neuronal tracts with subsequent measurement of FA and ADC is a useful
diagnostic tool for demonstrating patterns of neuronal tract involvement in neurodegenerative disease. In selected
tracts, FA and ADC values might act as surrogate markers for disease stage.
Background
Progressive supranuclear palsy (PSP) is a neurodegen-
erative disorder, with progressive motor, behavioural
and cognitive symptoms, ultimately leading to severe
handicap and death [1]. It is one of the most common
parkinsonian disorders, after idiopathic Parkinson dis-
ease (IPD) and dementia with lewy bodies (DLB) [2].
The clinical syndrome initially described by Steele,
Richardson and Olszewski [3] is characterized by verti-
cal gaze palsy, early postural instability, axial rigidity,
combined with apathy and dysexecutive symptoms,
and is referred to as Richardson’s syndrome [1]. Recent
clinical and neuropathological studies have revealed
other clinical presentations of PSP, dominated by
bradykinesia and postural instability and lacking many
of the frontal behavioural disturbances, so-called PSP-
parkinsonism [1].
Although often classified clinically as an atypical par-
kinsonian disorder, PSP is a tauopathy closely related to
corticobasal degeneration (CBD) and therefore also
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tia disorders. The diverse presentations make clinical
diagnosis difficult, especially in early stages of the dis-
ease, and there is a need for additional tools to support
the clinical diagnosis. Magnetic resonance imaging
(MRI) has so far proved to be the most useful diagnostic
investigation in clinical practice. Routine MRI can
demonstrate atrophy of the midbrain, putamen, superior
cerebellar peduncle (SCP) and frontal cortex, as well as
signal changes in the putamen and SCP [4,5]. The sensi-
tivity and specificity of these signs vary, but none of
them are completely specific for PSP [4-6].
MRI with diffusion tensor imaging (DTI) has enabled
measurement of the average and directional diffusivity
of water molecules in living tissue and has been used
for investigations of various brain disorders [7-9]. With
appropriate software the diffusion data can be further
processed to create a three-dimensional map that repre-
sents the white matter pathways. This technique is
called diffusion tensor tractography (DTT) and has
lately become a valuable tool for studying both healthy
and diseased white matter [10]. We have previously
demonstrated the potential use of DTT for differential
diagnosis of atypical parkinsonian disorders, including
PSP [11].
The inferior fronto-occipital fasciculus (IFO) is a large
white matter tract connecting the frontal, temporal and
occipital lobes. The IFO also constitutes one of the
major efferent and afferent neuronal projections to the
frontal lobes. It runs from the lateral aspect of the fron-
tal lobe, passing through the extreme and external cap-
sules, as well as the temporal lobe stem, before radiating
into the posterior temporal and occipital cortex [12,13].
The functions of the IFO are still poorly understood.
Apart from being a major association pathway between
the frontal and occipital lobes, there is anatomical evi-
dence that this pathway constitutes a connection
between the prefrontal cortex and auditory and visual
association cortex in the temporal lobe [13]. This might
form a part of the anatomical substrate for the sug-
gested association of the IFO with temporal lobe syn-
dromes, semantic processing, global aphasia, and
attentional set-shifting ability, although several other
association tracts that connect frontal cortex to more
posterior regions are affected in these conditions and
cognitive processes as well [13-16].
PSP-Richardson’s syndrome serves as a model for neu-
rodegenerative diseases with prominent fronto-subcorti-
cal involvement. As IFO connects the frontal lobes with
more posterior brain regions, it is therefore of great
clinical interest to investigate this pathway in PSP.
Although validated diagnostic neuropathological criteria
exist for PSP and the distribution of pathological lesions
are well described [1,17], the neuropathology of the IFO
has not been studied in PSP. Furthermore, the pattern
of neuronal tract degeneration underlying the different
PSP syndromes has not been characterized. The aim of
the present study was therefore to investigate whether
atrophy of the IFO occurs in PSP and if there is a corre-
lation between the clinical presentation in PSP and IFO
atrophy and diffusion changes. For reference, the corti-
cospinal tract (CST), which is often involved in PSP
[17], was chosen for comparison.
Methods
Subjects
Thirteen patients with progressive supranuclear palsy
(PSP; 8 male, 5 female; age (mean/SD) 70/6) with maxi-
mum disease duration of four years were recruited for
the study. The diagnosis of probable PSP was made
using established clinical criteria [18]. In addition, the
following specific symptoms were recorded after clinical
examination, review of medical records and interview
with caregiver: presence of vertical gaze palsy, severe
postural imbalance with falls and clinical fronto-subcor-
tical symptoms (the latter grouped in three categories:
dysexecutive symptoms, apathy/lack of initiative and
personality change). Disease severity in the PSP patients
was categorized using the Schwab & England (S&E)
scale for Parkinson’s disease [19]. Seven of the subjects
with PSP were moderately to severely affected with S&E
scale values of 20-40%, while the remaining six subjects
had S&E scale values of 60-80%. Twelve healthy age-
matched controls (7 male, 5 female; age (mean/SD) 69/
8), according to interview and clinical examination, were
recruited for comparison. Conventional magnetic reso-
nance imaging (MRI) was used to exclude the presence
of vascular or other focal lesions in PSP patients and
controls. All patients and controls gave written consent
to participate in the study, which was approved by the
Regional Ethics Committee for Research.
Imaging protocol
A 3.0 T Philips Intera MR scanner, equipped with an
eight-channel head coil was used. DTI was performed in
transversal slice orientation, using a single-shot EPI
sequence with diffusion encoding in 48 directions (b
values 0 and 800 s/mm
2). The acquired voxel size was 2
×2×2m m
3 in 50 slices, with a SENSE factor of 2.5.
The DTI protocol was followed by a high-resolution T2-
weighted sequence for identification of anatomical struc-
tures as well as signal changes.
Neuroradiological evaluation
All T2-weighted images in both patients and controls
were evaluated by the same neuroradiologist (DvW).
The presence or absence of frontal periventricular or
subcortical white matter changes, respectively, as well as
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mesencephalon, was recorded. Isolated subcortical white
matter lesions <3 mm were regarded as non-significant.
Tractography
The diffusion-weighted data were transferred to a work-
station and a correction algorithm for eddy current cor-
rection was applied prior to the tractography [20].
Tractography was then performed using the PRIDE
fiber-tracking tool supplied by Philips Medical Systems,
as described previously [11].
Tractography of the IFO and CST bilaterally was per-
formed based on the connection between two regions of
interest (ROI) in order to minimize the risk of including
other tracts. The atlases by Wakana et al [21] and Cat-
ani et al [22] were used to localize the tracts. For tracto-
graphy of the IFO, two ROIs were placed along the
course of the IFO in the coronal plane of the DTI images
at the level of the anterior commissure (Figure 1A) and
pontine crossing fibers (Figure 1B), respectively [12]. For
tractography of the CST, ROIs were placed in the inter-
nal capsule and pons, using transversal sections (not
shown) [21,22].
To analyze whether diffusion parameters change along
the course of the IFO, three small ROIs were fitted to
the pathway in cross section, to measure the fractional
anisotropy (FA) and the apparent diffusion coefficient
(ADC) in frontal (at the level of the genu corpus callo-
sum), middle (by the anterior commissure) and poster-
ior (in the region of the posterior part of corpus
callosum) parts of the tract (Figure 1C). Care was taken
not to include voxels outside the tract, to avoid partial
volume effects. Quantification of FA and ADC in either
individual ROIs or whole tract was performed using the
PRIDE fiber-tracking tool.
In this study, atrophy of the IFO was defined as a
reduction of tracked voxels determined by visual
inspection of DTT images. Only patients with a marked
reduction of tracked voxels in the frontal segment of the
IFO were judged to have significant atrophy.
Statistical analyses
All the statistical analyses were calculated using SPSS
14.0. The Mann-Whitney U-test was used for compari-
son of FA and ADC values, respectively, between
patients and controls, as well as for different ROIs in
the IFO. The mean of the values for the left and right
tract ROIs was used. For correlations between disease
stage and FA/ADC we used Spearman’s rank correlation
coefficient. The correlation between clinical fronto-sub-
cortical symptoms (minimum 2/3 of dysexecutive symp-
toms, apathy/lack of initiative and personality change)
and frontal atrophy of the IFO (defined by visual inspec-
tion) was evaluated statistically by a 2 × 2 contingency
table using Fisher’s exact test.
Results
Visual inspection of the T2-weighted images revealed
periventricular white matter changes in 9/13 subjects
with PSP, and 4/12 controls. Subcortical white matter
changes were only found in one subject with PSP and
one control. None of these changes were located along
the course of the IFO (Figure 2). Atrophy of the mesen-
cephalon ("humming bird sign”) was seen in 9/13 sub-
jects with PSP, while only 4/13 showed frontal cortical
atrophy. No regional atrophy was seen in controls.
The anatomy of the IFO generated by tractography in
the present study (Figure 3), closely resembled pre-
viously published data [12,13,16]. On visual inspection
4/13 of the patients with PSP showed a very marked
decrease in the number of tracked voxels in the frontal
region of the IFO, as illustrated in Figure 3. Diffusion
parameters could not be measured in the frontal ROI in
two of the 13 subjects with PSP, due to the near absence
ABC
Figure 1 Regions of interest for tractography of the IFO. Tractography of the IFO was performed using a two-ROI approach, based on the
connection between two regions of interest (ROI; arrows). The two ROIs were placed along the course of the IFO in the coronal plane of the
DTI images at the level of the anterior commissure (Figure 1A) and pontine crossing fibers (Figure 1B), respectively. For measurements of
regional differences in diffusion parameters, small ROIs were placed in the anterior, middle and posterior segments of the IFO (Figure 1C). The
location and size of each ROI is shown in the sagittal plane. For comparison with the location of the IFO, see Figure 3.
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patients, a significant difference was seen between PSP
and controls for both FA and ADC in the frontal ROI,
with lower FA and higher ADC in patients with PSP,
while no differences were seen in the middle and poster-
ior ROIs (Figure 4). Comparisons between different
ROIs were not performed for the CST. No significant
differences in mean FA or ADC, as measured in the
whole tract, were seen in the IFO or CST between
patients with PSP and controls (Table 1). However, the
standard deviation in both FA and ADC was much
greater in the IFO than in the CST, in both controls
and patients (Table 1).
The disease stage, as measured by the Schwab and
England scale, was compared with FA and ADC values
in the IFO. A significant correlation of 0.58 (p < 0.05)
was seen between disease stage and mean FA in the
frontal ROI of IFO, while no correlation was seen with
the whole IFO or the two posterior ROIs. In addition, a
correlation of -0.52 was seen between disease stage and
ADC values, but this correlation was not statistically sig-
nificant (p = 0.07). For the whole CST, there was a
highly significant negative correlation between disease
stage and ADC (-0.84; p < 0,001), while a statistically
non-significant correlation of 0.48 (p = 0.095) was seen
for FA values.
In a further analysis, clinical fronto-subcortical symp-
tomatology (at least two out of three of dysexecutive
symptoms, apathy and personality change) was com-
pared with the presence of frontal atrophy in the IFO.
In patients with a frontal clinical profile, four out of five
had significant atrophy of the frontal IFO, as determined
by visual inspection, and all of these four patients were
in an advanced disease stage (Schwab and England 20-
30%). None of the patients that had less than two of the
frontal clinical signs listed above showed any atrophy of
the IFO. A significant correlation (p < 0.01) was seen
between a fronto-subcortical clinical profile and the pre-
s e n c eo ff r o n t a la t r o p h yo ft h eI F O( T a b l e2 ) .O nr o u -
tine MRI, all patients with fronto-subcortical symptoms
also showed atrophy of the mesencephalon, while only
2/5 showed frontal lobe cortical atrophy.
Discussion
In the present study, we demonstrate that atrophy and
diffusion changes occur in two major nerve tracts (IFO
and CST) in patients with PSP using aggregated data
from DTT performed in individual patients. As the IFO
appears to be affected only in some of the patients with
PSP and frontal cognitive and behavioral symptoms, this
could explain the failure of previous studies to demon-
strate changes in diffusion parameters along the IFO
[25,27]. This finding further emphasizes the clinical
AB
Figure 2 Axial T2 FLAIR images along the course of the IFO.
MRI T2 FLAIR images, in a patient with PSP and IFO atrophy. The
figures show adjacent axial sections (A, B), which include the
external capsule (short arrows) and extreme capsule (long arrows).
The IFO passes through both these structures. In each section a
single minimal white matter signal intensity can be seen in the
right external capsule. Note the absence of signal changes in white
matter in general, in spite of the presence of mild frontal cortical
atrophy.
AB C
Figure 3 IFO morphology in patients and controls. Tractography of the right IFO in a control individual (A), a patient with PSP-parkinsonism
(B) and a patient with PSP and dysexecutive problems, apathy and personality change (Richardson’s syndrome; C). No difference in IFO
morphology can be seen between the control (A) and the patient with PSP-parkinsonism (B), while the patient with PSP-Richardson’s syndrome
shows severe atrophy of the frontal part of the IFO (C).
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changes in patients with PSP [1].
Previous imaging studies in PSP and other atypical
parkinsonian disorders have mainly focused on the
patterns of regional atrophy and their relation to clini-
cal diagnosis [4,5]. Using voxel-based DTI on a group
level, significant changes in diffusion parameters have
previously been reported in the superior longitudinal
fasciculus, anterior corpus callosum, arcuate fascicu-
lus, fornix, posterior thalamic radiation, internal cap-
sule, superior cerebellar peduncle and cerebellar white
matter in patients with PSP [25,27]. The IFO is a
major cortical association pathway connecting the
frontal and occipital lobes, with some branches also
terminating in the parietal and temporal lobes [12,16].
The IFO cannot be delineated by conventional MRI,
but can easily be visualized using tractography.
By using two or more ROIs, it is possible to delineate
the IFO and separate it from tracts that are adjacent
to the IFO during parts of its course [12]. If the
visualized tracts follow the same route as anatomically
defined neuronal pathways, it is reasonable to assume
that they are a good approximation of this pathway.
The anatomy of the IFO generated by tractography in
the present study closely resembles previously pub-
lished tractography and post-mortem dissection data
[12,13,16].
I ti si m p o r t a n tt op o i n to u tt h a tt h ei m a g e so ff i b e r
tracts produced by the tractography software probably
are an approximation of the underlying neuronal path-
ways. Each “fiber” is only a representation of voxels that
have similar macroscopic diffusion properties. For
instance, the DTT model used in this and most other
published studies does not differentiate between antero-
grade and retrograde connections and cannot separate
fiber tracts that cross, meet, merge or diverge [10].
Some of these problems can potentially be overcome by
using higher orders of tensors or spherical deconvolu-
tion [26]. However, these methods are not applicable to
the material in the present study.
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Figure 4 FA and ADC in the IFO. Box-plot of FA (A) and ADC (B; mm
2/s) values in the frontal, middle and posterior ROIs of the IFO (see text
for description of location). In the frontal ROI the FA value was significantly decreased (**; p < 0.01), while the ADC value was significantly
increased (*; p < 0.05), compared to controls. No difference in either FA or ADC was seen between controls and patients with PSP for the
middle or posterior ROIs.
Table 1 FA and ADC values in the IFO and CST
PSP Control
N1 31 2
Mean SD Mean SD
FAIFO 0.48 0.27 0.49 0.25
ADCIFO [mm
2/s] 0.95 0.53 0.93 0.46
FACST 0.59 0.03 0.59 0.03
ADCCST [mm
2/s] 0.84 0.05 0.81 0.04
Mean and standard deviation (SD) for FA and ADC calculated in whole nerve
tracts produced by tractography. There were no statistically significant
differences in mean FA and ADC between patients with PSP and controls.
Table 2 Correlation between clinical symptoms and
frontal atrophy of the IFO
Frontal atrophy
Frontal profile Yes No Total
Yes 4 1 5
No 0 8 8
Total 4 9 13
Correlation between clinical fronto-subcortical symptoms ("frontal profile"; i.e.
minimum 2/3 of dysexecutive symptoms, apathy/lack of initiative and
personality change) and frontal atrophy of the IFO (defined by visual
inspection), using a 2 × 2 contingency table (p < 0.01).
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duced by DTT are the mean of a large number of voxels
and the risk for partial volume effects are minimized.
On the other hand, variations in FA and ADC along the
course of the IFO will not be evident. By measuring FA
and ADC in small cross-sectional ROIs along the IFO,
the mean values will depend on only a few voxels with
increased risk for statistical errors. However, by placing
these small ROIs within the limits of the tract in the
DTI coronal image, the risk for partial volume effects
was minimized.
FA and ADC values differ between different tracts
[11], probably reflecting differences in axon density as
well as the degree of homogeneity of axon type and
direction. In this context, it is interesting to note the
substantial variation in mean FA and ADC values in the
IFO, as shown by the high standard deviation in both
patients and controls in Table 1. This might indicate
that the IFO has a heterogeneous composition, although
other technical reasons could also be involved. In con-
trast, very little variation was seen in either FA or ADC
in the CST, which consists almost entirely of large mye-
linated primary motor neuron fibers.
It is well known that the CST can be involved in PSP
[17] and one third of patients show pyramidal signs
[28]. We found no difference in FA or ADC values in
the CST between patients with PSP and controls. How-
ever, there was a strong correlation between ADC values
and disease severity in the CST in our study, and this
indicates that involvement of the motor cortex and the
CST increases gradually with disease progression in PSP.
In the present study, four out of the five patients with
classical PSP-Richardson’s syndrome had severe atrophy
of the frontal section of the IFO in DTT images, which
to our knowledge has not been demonstrated previously
in vivo. Neuropathological lesions in PSP can be wide-
spread in frontal, parietal and subcortical areas of the
brain, while the occipital lobes usually are unaffected
[1,17]. White matter degeneration in PSP is usually
moderate and is mainly due to neuronal or axonal
degeneration in the more severely affected areas [17].
This is in accordance with the present study, where
frontal subcortical white matter changes in routine MRI
were found in less than 10% of both subjects with PSP
and controls. Therefore, it seems reasonable to assume
that frontal atrophy of the IFO is secondary to the neu-
ronal degeneration in the frontal cortex, which occurs in
patients with PSP-Richardson’ss y n d r o m e[ 1 ] ,l e a v i n g
more posteriorly located parts of the IFO intact. On the
other hand, frontal cortical atrophy was only seen with
routine MRI in two of the five individuals that showed
clinical fronto-subcortical symptoms. This indicates that
significant neurodegenerative changes occur in the
frontal part of the IFO before macroscopically evident
frontal cortical atrophy can be seen.
In recent years it has become clear that the spectrum
of clinical presentation in PSP can be highly variable [1].
This is confirmed in the present study, where only five
out of thirteen patients with maximum of four years dis-
ease duration showed prominent fronto-subcortical
involvement, even though they fulfilled criteria for prob-
able PSP. Although there is a clinical rating scale for
PSP [29], we chose to use the Schwab and England rat-
ing scale for Parkinson’s disease as this provides a sim-
ple global rating of disease severity. Our results show
that disease severity measured in this way correlated
with diffusion parameters in both the IFO and CST.
Studies of the IFO using DTI and DTT have pre-
viously demonstrated decreased FA values in children
with autism spectrum disorders, traumatic brain injury
and following treatment with chemotherapy [30-32],
while we have not found any studies of the IFO in adult
neurodegenerative disease. The atrophy of the frontal
IFO observed in this study, correlated strongly with the
presence of signs of fronto-subcortical dysfunction, such
as dysexecutive problems, apathy and personality
change. The present results therefore indicate that atro-
phy of the frontal IFO is closely related to the cognitive
and behavioral symptoms seen in this neurodegenerative
disorder. Future studies should investigate the integrity
of other fronto-subcortical nerve tracts in PSP, in com-
bination with more detailed neuropsychological
evaluation.
DTI has been used for measurement of white matter
diffusion properties in a number of diseases, e.g. amyo-
trophic lateral sclerosis, schizophrenia, and Alzheimer
disease [7-9]. Tractography, on the other hand, has
mainly been used for neuroanatomical dissection of
white matter tracts in vivo in healthy volunteers and
patients with brain tumors, w h i l ei t su s ei nn e u r o d e -
generative disease has been rather limited
[10,11,23-25]. DTT could prove useful to investigate
the correlation between clinical symptoms and patterns
of neurodegeneration and atrophy in specific white
matter tracts. This might also be important for differ-
ential diagnosis, where the detection of specific pat-
terns of atrophy could point to a specific diagnosis
when the clinical history, symptoms and signs are
ambiguous, for example in the presence of early frontal
symptoms. More importantly, the neuroanatomy of
subcortical white matter networks underlying cognition
and behavior in both normal brain function as well as
in different brain diseases could be deduced by com-
bining measures of cognitive and behavioral function
with diffusion changes and atrophy of selected tracts
visualized by tractography [15].
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In conclusion, we have demonstrated that selective fron-
tal diffusion changes and atrophy of the IFO occurs in
PSP, in patients showing a fronto-subcortical clinical
phenotype. Furthermore, DTT can be a useful tool for
identifying selective patterns of neuronal tract atrophy
in neurodegenerative disease, which cannot be detected
by routine MRI. In selected tracts, FA and ADC values
might act as surrogate markers for disease stage.
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